tirzepatide 2mg dose Dosage Chart: Complete Dosing Schedule and Guidelines Dosing Explanation - Volume, Concentration,
Description
Here are the most common ones: Nausea Vomiting Constipation Loss of appetite Diarrhea A 2023 systematic review and meta-analysis found that of the above, nausea is the most common, happening in just over 20% of people taking Mounjaro

Advances in Chronic Kidney Disease

However, sore throat symptoms should prompt evaluation for alternative causes such as viral or bacterial infection, allergic rhinitis, or reflux disease

In withdrawal studies, continued use maintained ~25.3% weight loss vs

Do not attempt to partially inject, save, and reuse the remainder

All doses of tirzepatide and semaglutide were superior to placebo in achieving at least a 10% body weight reduction, with tirzepatide 15 mg (risk ratio = 10.51 [95% CI 7.55, 14.64]) and tirzepatide 10 mg (risk ratio = 8.84 [95% CI 6.35, 12.32]) being the most efficacious treatments (ESM Table 13)
